BerandaNZYM • VIE
add
Novozymes A/S
Tutup sebelumnya
€55,62
Rentang hari
€55,14 - €55,88
Rentang tahun
€50,12 - €65,48
Kapitalisasi pasar
171,18Â M DKK
Volume Rata-Rata
4,00
Rasio P/E
-
Hasil dividen
-
Bursa utama
CPH
Dalam berita
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (EUR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 7,95Â M | 694,17% |
Biaya operasional | — | — |
Penghasilan bersih | — | — |
Margin laba bersih | — | — |
Penghasilan per saham | 3,06 | — |
EBITDA | — | — |
Tarif pajak efektif | 19,53% | — |
Neraca
Total aset
Total liabilitas
| (EUR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 281,30 jt | — |
Total aset | 16,30 M | — |
Total liabilitas | 5,56 M | — |
Total ekuitas | 10,74 M | — |
Saham yang beredar | 467,40 jt | — |
Harga terhadap nilai buku | 2,42 | — |
Tingkat pengembalian aset | 3,05% | — |
Tingkat pengembalian modal | — | — |
Arus Kas
Perubahan kas bersih
| (EUR) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | — | — |
Kas dari operasi | 466,80Â jt | 77,76% |
Kas dari investasi | -165,00Â jt | -254,08% |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | -46,90Â jt | -481,30% |
Arus kas bebas | 562,32 jt | — |
Tentang
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
CEO
Didirikan
2000
Situs
Karyawan
10.582
